Prosthetic-joint-associated infections

Best Practice and Research: Clinical Rheumatology

Volumn 20, Issue 6, 2006, Pages 1045-1063

  Zimmerli, Werner ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

biofilm; diagnosis; prophylaxis; prosthetic joint infection; treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; CEFAMANDOLE; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; FLUCLOXACILLIN; FUSIDIC ACID; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MINOCYCLINE; PENICILLIN G; PLACEBO; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ALGORITHM; ANALGESIA; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTHROCENTESIS; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BIOFILM; BONE MARROW SUPPRESSION; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HOST RESISTANCE; HUMAN; INFECTIOUS ARTHRITIS; JOINT PROSTHESIS; LEUKOCYTE DIFFERENTIAL COUNT; MICROBIOLOGICAL EXAMINATION; NONHUMAN; OPTIC NERVE DISEASE; OSTEOARTHRITIS; PATIENT MOBILITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSTHESIS INFECTION; REVIEW; RISK FACTOR; SEPSIS; STAPHYLOCOCCUS INFECTION; SYNOVIAL FLUID; ANTIBIOTIC PROPHYLAXIS; DRUG EFFECT; INFECTION; METHODOLOGY; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOFILMS; HUMANS; JOINT PROSTHESIS; PROSTHESIS-RELATED INFECTIONS; SEPSIS;

EID: 33751200136     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2006.08.003     Document Type: Review

References (90)

1. Darouiche R.O. Treatment of infections associated with surgical implants. New England Journal of Medicine 350 14 (2004) 1422-1429
2. Zimmerli W., Trampuz A., and Ochsner P.E. Prosthetic joint infections. New England Journal of Medicine 351 16 (2004) 1645-1654
3. Costerton J.W., Montanaro L., and Arciola C.R. Biofilm in implant infections: its production and regulation. International Journal of Artificial Organs 28 11 (2005) 1062-1068
4. Trampuz A., Piper K., Hanssen A., et al. Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. Journal of Clinical Microbiology 441 (2006) 628-631
5. Trampuz A., Steckelberg J., Osmon D., et al. Advances in the laboratory diagnosis of prosthetic joint infection. Reviews in Medical Microbiology 14 (2003) 1-14
6. Brause B. Infections with prostheses in bones and joints. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases. 6th edn (2005), WB Saunders, Washington, DC 1332-1337
7. Ragni M.V., Crossett L.S., and Herndon J.H. Postoperative infection following orthopaedic surgery in human immunodeficiency virus-infected hemophiliacs with CD4 counts < or = 200/mm3. The Journal of Arthroplasty 10 6 (1995) 716-721
8. Wilson M.G., Kelley K., and Thornhill T.S. Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases. The Journal of Bone and Joint Surgery. American Volume 72 6 (1990) 878-883
9. Poss R., Thornhill T.S., Ewald F.C., et al. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clinical Orthopaedics and Related Research 182 (1984) 117-126
10. Berbari E.F., Hanssen A.D., Duffy M.C., et al. Risk factors for prosthetic joint infection: case-control study. Clinical Infectious Diseases 27 5 (1998) 1247-1254
11. Schafroth M., Zimmerli W., Brunazzi M., and Ochsner P.E. Infections. In: Ochsner P.E. (Ed). Total Hip Replacement: Implantation Technique and Local Complications (2003), Springer, Berlin 65-90
12. Ainscow D.A., and Denham R.A. The risk of haematogenous infection in total joint replacements. The Journal of Bone and Joint Surgery. British Volume 66 4 (1984) 580-582
13. Murdoch D.R., Roberts S.A., Fowler Jr. V.G., et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clinical Infectious Diseases 32 4 (2001) 647-649
14. Darouiche R.O. Device-associated infections: a macroproblem that starts with microadherence. Clinical Infectious Diseases 33 9 (2001) 1567-1572
15. Zimmerli W., Waldvogel F.A., Vaudaux P., and Nydegger U.E. Pathogenesis of foreign body infection: description and characteristics of an animal model. The Journal of Infectious Diseases 146 4 (1982) 487-497
16. Elek S.D., and Conen P.E. The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. British Journal of Experimental Pathology 38 6 (1957) 573-586
17. Giulieri S.G., Graber P., Ochsner P.E., and Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 32 4 (2004) 222-228
18. Laffer R.R., Graber P., Ochsner P.E., and Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clinical Microbiology and Infection 12 5 (2006) 433-439
19. Zimmerli W., Lew P.D., and Waldvogel F.A. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. The Journal of Clinical Investigation 73 4 (1984) 1191-1200
20. Ramage G., Tunney M.M., Patrick S., et al. Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials 24 19 (2003) 3221-3227
21. Trampuz A., Osmon D., Hanssen A., et al. Molecular and antibiofilm approaches to prosthetic joint infection. Clinical Orthopaedics and Related Research 414 (2003) 69-88
22. Gotz F. Staphylococcus and biofilms. Molecular Microbiology 43 6 (2002) 1367-1378
23. Yao Y., Sturdevant D.E., and Otto M. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. The Journal of Infectious Diseases 191 2 (2005) 289-298
24. Williams R.J., Henderson B., Sharp L.J., and Nair S.P. Identification of a fibronectin-binding protein from Staphylococcus epidermidis. Infection and Immunity 70 12 (2002) 6805-6810
25. König D., Perdreau-Remington F., Rütt J., et al. Slime production of Staphylococcus epidermidis. Acta Orthopaedica Scandinavica 69 (1998) 523-526
26. Schwank S., Rajacic Z., Zimmerli W., and Blaser J. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrobial Agents and Chemotherapy 42 4 (1998) 895-898
27. Davies D.G., Parsek M.R., Pearson J.P., et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280 5361 (1998) 295-298
28. Maderazo E.G., Judson S., and Pasternak H. Late infections of total joint prostheses. A review and recommendations for prevention. Clinical Orthopaedics and Related Research 229 (1988) 131-142
29. Bauer T.W., Parvizi J., Kobayashi N., and Krebs V. Diagnosis of periprosthetic infection. The Journal of Bone and Joint Surgery. American Volume 88 (2006) 869-882
30. Meehan A.M., Osmon D.R., Duffy M.C., et al. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clinical Infectious Diseases 36 7 (2003) 845-849
31. Tattevin P., Cremieux A.C., Pottier P., et al. Prosthetic joint infection: when can prosthesis salvage be considered?. Clinical Infectious Diseases 29 2 (1999) 292-295
32. Brandt C.M., Sistrunk W.W., Duffy M.C., et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clinical Infectious Diseases 24 5 (1997) 914-919
33. Tigges S., Stiles R.G., and Roberson J.R. Appearance of septic hip prostheses on plain radiographs. American Journal of Roentgenology 163 2 (1994) 377-380
34. Stumpe K.D., Notzli H.P., Zanetti M., et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology 231 2 (2004) 333-341
35. Zimmerli W., and Ochsner P.E. Management of infection associated with prosthetic joints. Infection 31 2 (2003) 99-108
36. Corstens F., and van der Meer J. Nuclear medicine's role in infection and inflammation. Lancet 354 (1999) 765-770
37. Smith S.L., Wastie M.L., and Forster I. Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clinical Radiology 56 3 (2001) 221-224
38. Ivancevic V., Perka C., Hasart O., et al. Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab' fragment in patients with previous joint surgery. European Journal of Nuclear Medicine and Molecular Imaging 29 4 (2002) 547-551
39. Love C., Pugliese P.V., Afriyie M.O., et al. 5. Utility of F-18 FDG imaging for diagnosing the infected joint replacement. Clinical Positron Imaging 3 4 (2000) 159
40. Shih L.Y., Wu J.J., and Yang D.J. Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clinical Orthopaedics and Related Research 225 (1987) 238-246
41. Trampuz A., Hanssen A., Osmon D., et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. The American Journal of Medicine 117 (2004) 556-562
42. Hughes J.G., Vetter E.A., Patel R., et al. Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. Journal of Clinical Microbiology 39 12 (2001) 4468-4471
43. Pandey R., Berendt A.R., and Athanasou N.A. Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. The OSIRIS Collaborative Study Group. Oxford Skeletal Infection Research and Intervention Service. Archives of Orthopaedic and Trauma Surgery 120 10 (2000) 570-574
44. Atkins B.L., Athanasou N., Deeks J.J., et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. Journal of Clinical Microbiology 36 10 (1998) 2932-2939
45. Spangehl M.J., Masri B.A., O'Connell J.X., and Duncan C.P. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. The Journal of Bone and Joint Surgery. American Volume 81 5 (1999) 672-683
46. Widmer A.F. New developments in diagnosis and treatment of infection in orthopedic implants. Clinical Infectious Diseases 33 supplement 2 (2001) S94-S106
47. Widmer A.F., Frei R., Rajacic Z., and Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. The Journal of Infectious Diseases 162 1 (1990) 96-102
48. Widmer A.F., Wiestner A., Frei R., and Zimmerli W. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrobial Agents and Chemotherapy 35 4 (1991) 741-746
49. Zimmerli W., Frei R., Widmer A.F., and Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. The Journal of Antimicrobial Chemotherapy 33 5 (1994) 959-967
50. Zimmerli W., Widmer A.F., Blatter M., et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. The Journal of the American Medical Association 279 19 (1998) 1537-1541
51. Widmer A.F., Gaechter A., Ochsner P.E., and Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clinical Infectious Diseases 14 6 (1992) 1251-1253
52. Zimmerli W. Modèles d'infection sur corps étranger. Médecine et Maladies Infectieuses 27 Spécial (1997) 181-187
53. Trebse R., Pisot V., and Trampuz A. Treatment of infected retained implants. The Journal of Bone and Joint Surgery. British Volume 87 2 (2005) 249-256
54. Shirtliff M.E., Calhoun J.H., and Mader J.T. Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits. The Journal of Antimicrobial Chemotherapy 48 2 (2001) 253-258
55. Greenberg R.N., Newman M.T., Shariaty S., and Pectol R.W. Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis. Antimicrobial Agents and Chemotherapy 44 1 (2000) 164-166
56. Frippiat F., Meunier F., and Derue G. Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections. The Journal of Antimicrobial Chemotherapy 54 6 (2004) 1158 [author reply 1159]
57. Drancourt M., Stein A., Argenson J.N., et al. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. The Journal of Antimicrobial Chemotherapy 39 2 (1997) 235-240
58. Trampuz A., and Zimmerli W. New strategies for the treatment of infections associated with prosthetic joints. Current Opinion in Investigational Drugs 6 2 (2005) 185-190
59. Drew R.H., Perfect J.R., Srinath L., et al. Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group. The Journal of Antimicrobial Chemotherapy 46 5 (2000) 775-784
60. Razonable R.R., Osmon D.R., and Steckelberg J.M. Linezolid therapy for orthopedic infections. Mayo Clinic Proceedings 79 9 (2004) 1137-1144
61. Bressler A.M., Zimmer S.M., Gilmore J.L., and Somani J. Peripheral neuropathy associated with prolonged use of linezolid. The Lancet Infectious Diseases 4 8 (2004) 528-531
62. Latronico N., Fenzi F., Recupero D., et al. Critical illness myopathy and neuropathy. Lancet 347 9015 (1996) 1579-1582
63. Carpenter C.F., and Chambers H.F. Daptomycin another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clinical Infectious Diseases 38 7 (2004) 994-1000
64. Tsukayama D.T., Wicklund B., and Gustilo R.B. Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics 14 8 (1991) 841-844
65. Tsukayama D.T., Estrada R., and Gustilo R.B. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. The Journal of Bone and Joint Surgery. American Volume 78 4 (1996) 512-523
66. Schoifet S.D., and Morrey B.F. Treatment of infection after total knee arthroplasty by debridement with retention of the components. The Journal of Bone and Joint Surgery. American Volume 72 9 (1990) 1383-1390
67. Crockarell J.R., Hanssen A.D., Osmon D.R., and Morrey B.F. Treatment of infection with debridement and retention of the components following hip arthroplasty. The Journal of Bone and Joint Surgery. American Volume 80 9 (1998) 1306-1313
68. Deirmengian C., Greenbaum J., Lotke P.A., et al. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. The Journal of Arthroplasty 18 7 supplement 1 (2003) 22-26
69. Marculescu C.E., Berbari E.F., Hanssen A.D., et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clinical Infectious Diseases 42 4 (2006) 471-478
70. Berbari E.F., Osmon D.R., Duffy M.C., et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clinical Infectious Diseases 42 2 (2006) 216-223
71. Ure K.J., Amstutz H.C., Nasser S., and Schmalzried T.P. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. The Journal of Bone and Joint Surgery. American Volume 80 7 (1998) 961-968
72. Hope P.G., Kristinsson K.G., Norman P., and Elson R.A. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. The Journal of Bone and Joint Surgery. British Volume 71 5 (1989) 851-855
73. Raut V.V., Siney P.D., and Wroblewski B.M. One-stage revision of infected total hip replacements with discharging sinuses. The Journal of Bone and Joint Surgery. British Volume 76 5 (1994) 721-724
74. Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement?. The Journal of Bone and Joint Surgery. British Volume 85 5 (2003) 637-640
75. Westrich G., Salavati E., and Braus B. Postoperative infection. 1st edn. In: Bono J.V., McCarty J.C., Thornhill T.S., Bierbam E., and Turner R.H. (Eds) (1999), Springer-Verlag, New York, NY 371-390
76. Colyer R.A., and Capello W.N. Surgical treatment of the infected hip implant. Two-stage reimplantation with a one-month interval. Clinical Orthopaedics and Related Research 298 (1994) 75-79
77. van de Belt H., Neut D., Schenk W., et al. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthopaedica Scandinavica 72 6 (2001) 557-571
78. Josefsson G., Gudmundsson G., Kolmert L., and Wijkstrom S. Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A five-year survey of 1688 hips. Clinical Orthopaedics and Related Research 253 (1990) 173-178
79. Suter F., Avai A., Fusco U., et al. Teicoplanin versus cefamandole in the prevention of infection in total hip replacement. European Journal of Clinical Microbiology & Infectious Diseases 13 10 (1994) 793-796
80. Hill C., Flamant R., Mazas F., and Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet 1 8224 (1981) 795-796
81. Nelson C.L., Green T.G., Porter R.A., and Warren R.D. One day versus seven days of preventive antibiotic therapy in orthopedic surgery. Clinical Orthopaedics and Related Research 176 (1983) 258-263
82. Gatell J.M., Garcia S., Lozano L., et al. Perioperative cefamandole prophylaxis against infections. The Journal of Bone and Joint Surgery. American Volume 69 8 (1987) 1189-1193
83. Wymenga A., van Horn J., Theeuwes A., et al. Cefuroxime for prevention of postoperative coxitis. One versus three doses tested in a randomized multicenter study of 2,651 arthroplasties. Acta Orthopaedica Scandinavica 63 1 (1992) 19-24
84. Mauerhan D.R., Nelson C.L., Smith D.L., et al. Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin. The Journal of Bone and Joint Surgery. American Volume 76 1 (1994) 39-45
85. Nungu K.S., Olerud C., Rehnberg L., et al. Prophylaxis with oral cefadroxil versus intravenous cefuroxime in trochanteric fracture surgery. A clinical multicentre study. Archives of Orthopaedic and Trauma Surgery 114 6 (1995) 303-307
86. Ahlberg A., Carlsson A.S., and Lindberg L. Hematogenous infection in total joint replacement. Clinical Orthopaedics and Related Research 137 (1978) 69-75
87. Steckelberg J., and Osmon D. Prosthetic joint infection. In: Bisno A.L., and Waldvogel F.A. (Eds). Infections Associated with Indwelling Medical Devices. 3rd edn (2000), American Society for Microbiology, Washington, DC 173-209
88. Pallasch T., and Wahl M. Focal infection: new age or ancient history. Endodontic Topics 4 (2003) 32-45
89. American Academy of Orthopaedic Surgeons. Antibiotic prophylaxis for dental patients with total joint replacement. Document no. 1014. http://www.aaos.org/wordhtml/papers/advistmt/1014.htm
90. American Academy of Orthopaedic Surgeons. Antibiotic prophylaxis for urological patients with total joint replacements. Document no. 1023. http://www.aaos.org/wordhtml/papers/advistmt/1023.htm